HUYABIO International
12531 High Bluff Drive
Suite 138
San Diego
California
92130
United States
Website: https://huyabio.com/
About HUYABIO International
HUYABIO has now grown to be the leader in globalizing China’s pharmaceutical innovation. Meeting the challenge of tomorrow’s unmet medical needs requires utilizing the talents of Chinese researchers and helping to move their discoveries forward. Our HUYABIO teams in San Diego, Tokyo, Dublin, Montreal, Seoul and our eight China offices are committed to building relationships that enable candidate compounds to be more accessible internationally. With diverse approaches including in-licensing, alliances, co-development, research funding and creative financial partnerships, HUYABIO is poised to bring China’s healthcare discoveries to benefit the rest of the world.
When joining us at HUYABIO, you become part of the team, right here and now. Where you are empowered to lead and perform at your best. Where you collaborate across disciplines, borders, and continents. HUYABIO International is committed to creating a diverse environment and is proud to be an equal opportunity employer.
86 articles about HUYABIO International
-
HUYA Bioscience International Announces First Pre-IND Outcome for a Development Stage Compound Sourced From China
4/14/2008
-
HUYA Bioscience International Announces World-Class Clinical Advisory Team for New Anti-Arrhythmic Compound
3/3/2008
-
HUYA Bioscience International Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound; Data Supports Desirable Safety Profile
3/3/2008
-
HUYA Bioscience International Announces Clinical Trial Milestones in China for Promising New Anti-Arrhythmic Compound
3/3/2008
-
HUYA Bioscience International Licenses Clinical Stage Anti-Arrhythmic Compound from the Shanghai Institute of Materia Medica
10/2/2007
-
HUYA Bioscience International and Chipscreen Biosciences Initiate a Phase I Clinical Cancer Trial
5/23/2007